Graft infections are one of the most challenging issues in surgery with an incidence of 0.7 to 7 per cent, with femoral site infections being the most common (13% incidence). The gold standard treatment has been graft removal, wide debridement, and extra-anatomical bypass. Routine excision of infected peripheral arterial grafts and vascular reconstruction with extraanatomic conduits are associated with mortality rates ranging from 10 to 30 per cent and amputation rates of up to 70 per cent. As a result of the high morbidity and mortality associated with this approach, selective graft preservation techniques have been developed. Newer treatment plans discuss preservation of the graft with debridement and coverage of the infected region. Better wound care, nutrition optimization, and robust flap coverage have led to significantly improved graft salvage, lower amputation rates, and improved outcomes. The objective of this study was to evaluate the Veterans Affairs (VA) experience with flap coverage for femoral vascular graft infections. A retrospective review was conducted of all VA data from 1997 to 2008 with inclusion criteria of patients with deep groin wound infections requiring flap coverage after femoral bypass surgery. Eleven such patients were identified with a mean age of 73 years and with multiple comorbidities (hypertension, malnutrition, diabetes mellitus, chronic obstructive pulmonary disease, coronary artery disease, chronic renal insufficiency). Patients presented with wound drainage, exposed graft, hematoma, perigraft fluid collection, and pseudoaneurysm. Treatment protocol included: 1) aggressive debridement of the wound bed; 2) early soft tissue (flap) coverage; 3) wound vacuum assisted closure device or frequent dressing changes; and 4) skin graft once the bed was prepared. Eighty-two per cent of wounds had positive cultures with equal numbers of patients with Staphylococcus epidermidis, Pseudomonas, Escherichia coli (22%), and higher methicillin-resistant Staphylococcus aureus (33%), whereas in the literature Staphylococcus is the most common (greater than 50%). Average hospital length of stay was 94 days with average follow up at 10 months. Fifty-five per cent graft salvage (one Dacron [50%], two polytetrafluoroethylene [33%], two saphenous vein graft [100%], one cryovein [100%]) was achieved with 91 per cent limb salvage. Complications included graft blowout (two) requiring partial flap loss (one), retroperitoneal hematoma (one), limb loss (one), sepsis (one), and death (one). Infected vascular grafts remain a challenging problem requiring multidisciplinary care. Careful debridement and aggressive wound care followed by selective flap coverage appears to decrease morbidity and increase graft and limb salvage.
The authors attempted to develop a reliable and reproducible new animal model in which the blood-flow velocity to a flap could be varied. This model was utilized to study the effects of different blood-flow velocities on the patency rate of small 1- to 2-mm vessels after common microsurgical procedures. Male Sprague-Dawley rats, weighing 450 to 550 gm, were used to develop a model creating either a "high blood flow" or a "low blood flow" state by ligating the rat femoral artery, either distally or proximally, to an epigastric artery based on a groin cutaneous flap. Blood-flow velocities were measured by microvascular flowmeter, and statistical analysis was performed on the data collected. The model was next used to determine the effects of different blood-flow velocities on the patency rates of rat femoral vessels after primary anastomosis vs interpositional vein grafting. Interpositional vein grafting was subsequently repeated by a more senior microsurgeon, to determine the potential effects of increased surgical experience. The animal model was reliable, easily reproducible, and efficacious in producing two separate groups of rats with significantly different blood-flow velocities (3.98 vs. 2.14 +/- 0.5 ml/min), as was confirmed by electromagnetic flowmeter and statistical analysis. In experienced hands, decreased blood-flow velocity did not result in decreased patency rates of these small vessels after primary anastomosis, or even after vein grafting. As long as microvascular vein grafting and primary anastomosis procedures are done properly, even 1-mm vessels can tolerate significantly decreased blood-flow velocity without a decreased patency rate. Although many known factors can contribute to thrombosis and failure of anastomoses in clinical microsurgery, blood-flow velocity appears not to be a significant factor. Also described is a new, reliable animal model that can be used in small-vessel blood-flow velocity studies.
Many fail to know the names and ranks of contributors among members of different OR teams. Even our most reliable nursing team was inconsistent at identification information from collaborating practitioners. Despite universally acknowledged benefits, participants rarely learned basic background identification data beyond their own team. Those surveyed all desired improving identifications with suggestions including sterile name and rank tags and proper notification of entry and exit from the OR. Because successful collaborations require appropriate level task delegations, participants believed knowing a resident's name and rank is important not only for team bonding but also for safety. Academia furthermore demands fair performance evaluations, and displaying them clearly improves recall. Refining our own identified gaps in OR communications may demonstrate improved teamwork and safer task delegations and perhaps even stimulate other performance benefits for academic ORs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.